ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA

被引：0
|
作者：
Semon, Gregory [1 ]
Straughn, Angela [2 ]
Hardman, Claire [3 ]
Steel, Barbara [2 ]
Ekeh, Akpofure [1 ]
机构：
[1] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA
[2] Miami Valley Hosp, Dayton, OH USA
[3] Wright State Phys, Dept Surg, Dayton, OH USA
来源：
CRITICAL CARE MEDICINE | 2021年 / 49卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
615
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [1] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    [J]. NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [2] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    [J]. Neurocritical Care, 2021, 35 : 255 - 261
  • [3] ANDEXANET ALFA AFTER 4-FACTOR PCC ADMINISTRATION FOR INTRACRANIAL HEMORRHAGE: A CASE SERIES
    Bradshaw, Paige
    Keegan, Shaun
    Foertsch, Madeline
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 375 - 375
  • [4] Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
    Bradshaw, Paige Garber
    Keegan, Shaun
    Foertsch, Madeline
    Yang, George L.
    Ngwenya, Laura B.
    Srinivasan, Vasisht
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (02) : 295 - 300
  • [5] Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
    Paige Garber Bradshaw
    Shaun Keegan
    Madeline Foertsch
    George L. Yang
    Laura B. Ngwenya
    Vasisht Srinivasan
    [J]. Journal of Thrombosis and Thrombolysis, 2022, 54 : 295 - 300
  • [6] Concomitant andexanet alfa and 4 F-PCC for Factor Xa inhibitor associated intracranial hemorrhage
    Orban III, James E.
    Ruckel, Cassidy
    Harlan, Sarah
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [7] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298
  • [8] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Troyer, Camille
    Nguyen, Wesley
    Xie, Annie
    Wimer, Dexter
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (01) : 149 - 155
  • [9] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Camille Troyer
    Wesley Nguyen
    Annie Xie
    Dexter Wimer
    [J]. Journal of Thrombosis and Thrombolysis, 2023, 55 : 149 - 155
  • [10] Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
    Rauch, Sebastian
    Mueller, Hans-Peter
    Dreyhaupt, Jens
    Ludolph, Albert C.
    Kassubek, Jan
    Althaus, Katharina
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
12345